Insights

Updating results

Showing results 1 - 24 of 40 Results per page:

No results found.

  • Advertising, Marketing & Regulatory
  • Artificial Intelligence
  • Automotive
  • Cannabis
  • Chemical
  • Chemical AI
  • Cleantech
  • Copyright & Digital Media
  • Electrical & Computer Technology
  • Financial Technology
  • Industrial Designs
  • IP Management & Strategic Counselling
  • Licensing & Transactions
  • Life Sciences
  • Litigation & Contentious IP
  • Mechanical & Industrial Processes
  • Medical Technology
  • Nanotechnology
  • Oil & Gas
  • Patents
  • Plant Breeders’ Rights
  • Privacy & Data Protection
  • Psychedelics
  • Quantum Technologies
  • Trademarks
  • Nicholas Aitken
  • Ian Anderson
  • Adam Aucoin
  • William Audet
  • Ryan Baker
  • Christie J. C. Bates
  • Stephen Beney
  • Brett Benham
  • Daniel Bereskin, C.M., K.C.
  • Janice M. Bereskin
  • Shaivi Bhatt
  • Adam Bierylo
  • Paul David Blizzard
  • Adam Bobker
  • Chantalle Briggs
  • Jonathan G. Burkinshaw
  • Isi Caulder
  • Brigitte Chan
  • Wynnie Chan
  • Mina Chana
  • Herman Cheung
  • Toba Cooper
  • Noel Courage
  • Carmela De Luca
  • Ryan De Vries
  • Reshika Dhir
  • Meghan Dillon
  • Rutherford Exius
  • Michael Fenwick
  • Patricia Folkins
  • Cameron Gale
  • Matthew John Graff
  • Louis-Pierre Gravelle
  • Micheline Gravelle
  • Kyungwon Ha
  • Hasnain Hasni
  • Gail Hung
  • Nicole Hunter
  • Jason Hynes
  • Alissa Hyppolite
  • Ellen Kiernan
  • Simone Knott
  • Michael Kovacevic
  • Ray Kovarik
  • Chris Kowal
  • Victor Krichker
  • Manvinder Lalh
  • Ashley Lam
  • Dominique Lambert
  • François Larose
  • Maddie Lynch
  • Joanna Ma
  • Alfred A. Macchione
  • R. Scott MacKendrick
  • Don MacOdrum
  • Sandra Marone
  • Andrew McIntosh
  • Melissa J. McKeon
  • Ian McMillan
  • Philip C. Mendes da Costa
  • Hailey Min
  • David Morrison
  • Luba Naiberger
  • Paige Newman
  • Andrea Ngo
  • Tony Orsi
  • Ainslie Parsons
  • Moïse Perreault
  • Justin Philpott
  • Scott Pundsack
  • James Raakman
  • Bhupinder Randhawa
  • Sunil Rao
  • Coralee Ridder
  • Mark L. Robbins
  • Jane Sarjeant
  • Gurbir Sidhu
  • Timothy Sinnott
  • Parnian Soltanipanah
  • Josh Spicer
  • David St-Martin
  • Kate Stewart-Tiralongo
  • Robert Storey
  • Jessica R. Sudbury
  • Melanie Szweras
  • Andrea Uetrecht
  • Maria Wei
  • Tamara Céline Winegust
  • Leanne Young
  • Jennie Yum
  • Previous 30 days
  • Previous 90 days
  • Previous year
  • From to

Explore our Insights

February 16, 2024
2023 Year in Review: Privacy
By Parnian Soltanipanah and Melanie Szweras
July 27, 2023
CIPO’s Patent Fee Increases for 2024
By Dominique Lambert and Melanie Szweras
July 25, 2023
The Untenable Standard of Anonymized Data
By: Melanie Szweras and Parnian Soltanipanah
July 4, 2023
Second Interim Guidance Proposed by the PMPRB
By Melanie Szweras and Chantalle Briggs
June 22, 2023
Case Comment on Privacy Commissioner of Canada v Facebook, Inc [2023 FC 533]
By Melanie Szweras and Parnian Soltanipanah
June 6, 2023
Federal Court of Appeal Clarifies Test for Inducing Infringement for Generic/Biosimilar Drugs
By Melanie Szweras and Nyrie Israelian
March 30, 2023
Privacy Update – New Laws and Cases of Interest
By: Melanie Szweras, William Audet, Prudence Etkin, Parnian Soltanipanah, and Julia London
January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection
By Maddie Lynch and Melanie Szweras
December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!
By Melanie Szweras and Chantalle Briggs
November 16, 2022
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims
By: Melanie Szweras, Ian McMillan, and Nicole LaBerge
November 10, 2022
PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued
By Nyrie Israelian, Parnian Soltanipanah, Melanie Szweras, Noel Courage 
September 23, 2022
Class certification for privacy breaches, not so easy to come by
By Melanie Szweras, Parnian Soltanipanah and William Audet

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

July 6, 2022
New front-of-package nutrition symbol requirement for prepackaged foods
By Melanie Szweras and Iris Cheung
June 9, 2022
Amendments to the Canadian Patent Rules are coming into force on October 3, 2022
By Melanie Szweras, Patricia Folkins and Dominique Lambert
June 2, 2022
Federal Court sets aside Minister of Health’s approval of RUZURGI for the second time over data protection dispute
April 27, 2022
Competition Bureau and Health Canada to cooperate to facilitate competition
By Melanie Szweras and Luca Manfredi
March 8, 2022
Federal Court Interprets Patent Act Amendments to Prior User Rights Provisions
By Melanie Szweras and Nyrie Israelian
February 4, 2022
AI in Focus: Brain-Computer Interface Technologies
By Chantalle Briggs and Melanie Szweras
January 25, 2022
2021 Year in Review: Life Sciences
By Melanie Szweras and Alissa Hyppolite
November 19, 2021
Federal Court finds Minister of Health’s refusal of BELSOMRA CSP unreasonable, remits for redetermination
By Melanie Szweras and Nyrie Israelian
September 23, 2021
Another Positive Outcome for Diagnostic Methods from the Patent Appeal Board
By Melanie Szweras and Parnian Soltanipanah
August 11, 2021
Smoothing Out the Patent Prosecution Process for Diagnostic Methods in Canada
By Melanie Szweras and Keon Coleman
July 9, 2021
Inducing Infringement by Product Monographs & Skill and Judgment in Medical Use Claims: Key Takeaways from the Federal Court’s decision in Hoffman-La Roche Limited v Sandoz Canada Inc.
By Melanie Szweras, Scott MacKendrick & Maddie Lynch
June 2, 2021
Dosage Regimens Affirmed in Canada Again
By Melanie Szweras, Andrea Uetrecht and Madelaine Lynch
Loading...

Showing results 1 - 24 of 40 Results per page:

No results found.

Subscribe to our newsletter

You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site is registered on wpml.org as a development site.